Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 3/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 2/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.40 |
| ▸ | FAP | Q12884 | 1/20 | 0.40 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.40 |
| ▸ | NTMT1 | Q9BV86 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31467770 | 0.94 | APLNR (0.47) | APLNROPRM1OPRK1F2DPP4 | |
| SCHEMBL34464910 | 0.94 | ACE (0.47) | ACEOPRM1OPRK1F2DPP4 | |
| SCHEMBL29607850 | 0.91 | OPRM1 (0.49) | ACEOPRM1OPRK1F2CXCR4 | |
| SCHEMBL30471672 | 0.90 | F2 (0.39) | ACEF2DPP4DPP8DPP9 | |
| SCHEMBL29416313 | 0.90 | OPRM1 (0.41) | ACEOPRM1OPRK1F2 | |
| SCHEMBL31437195 | 0.89 | APLNR (0.46) | APLNRACEOPRM1OPRK1CXCR4 | |
| SCHEMBL31165891 | 0.89 | NRP1 (0.41) | APLNROPRM1OPRK1CXCR4 | |
| SCHEMBL5507610 | 0.89 | NRP1 (0.48) | ACEOPRM1OPRK1F2CXCR4 | |
| SCHEMBL5507620 | 0.89 | NRP1 (0.48) | ACEOPRM1OPRK1F2CXCR4 | |
| SCHEMBL31220452 | 0.89 | F2 (0.49) | ACEOPRM1OPRK1F2DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025037993-A1 | DOSAGE FORM FOR PEPTIDE AGENTS | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |